BioNTech investigates cancer vaccine BNT12...BionTech SE, which has been very successful in the field of corona vaccines, is starting phase II tests with its colorectal cancer candidate BNT122. more ➔
Advent France Biotechnology launches €8...Advent France Biotechnologys has launched a second biotech seed fund with a first close at €86m. Since 2017, the French state fund has financed 15 startups in France, Spain, Belgium and Ireland with … more ➔
UK clears the way for gene-edited cropsPost-Brexit, UK ditches the strict EU regulation for genetic engineering: in future, gene-edited crops will be assessed just like any other new variety, the government said. more ➔
Team identifies factors for COVID-19 vacci...A comparison of immune correlates of AstraZeneca’s Phase II/III COVID-19 vaccine trial shows what antibodiy titer is required to prevent symptomatic disease. more ➔
AstraZeneca invests in saRNA platformAstraZeneca has teamed up with RNA vaccine and therapeutic developer VaxEquity, investing US$195m in milestone payments alone. more ➔
EIF supports translational med with €25mThe EIF has invested €25m in the Prague-based i&i Biotech Fund I to boost biomedical tech transfer in Austria and Eastern Europe. more ➔
Boehringer Ingelheim: Takeover in immunoon...Boehringer Ingelheim has acquired Texan biotech Abexxa Biologics Inc., further expanding its cancer immunotherapy pipeline. more ➔
AstraZeneca puts €307m in Irish Alexion...Following the $39bn Alexion buy-out completed in July, AstraZeneca plc announced it will invest €307m in the company’s producion site near Dublin. more ➔
Bayer: Peptide deal with GubraBayer AG has joined forces with young Danish biotech Gubra ApS in a research collaboration and license agreement for the development of peptide therapeutics to treat cardiorenal diseases. more ➔
Foundation launches Harvard research hubThe Novo Nordisk Foundation is investing US$47.5m into a research collaboration with the Broad Institute of MIT and Harvard, intending to dive into the disease mechanisms of diabetes and obesity. more ➔
